This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
| Device | P190023S002 |
| Classification Name | None |
| Applicant | |
| PMA | P190023 |
| Supplement | S002 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P190023 | Original Filing | |
| S011 | 2022-11-18 | 30-day Notice |
| S010 | 2022-08-12 | Real-time Process |
| S009 | 2022-07-01 | 30-day Notice |
| S008 | 2022-06-08 | 30-day Notice |
| S007 | 2022-04-18 | 30-day Notice |
| S006 | 2022-02-18 | 30-day Notice |
| S005 | ||
| S004 | 2021-11-08 | 30-day Notice |
| S003 | 2021-10-25 | 135 Review Track For 30-day Notice |
| S002 | ||
| S001 | 2021-10-15 | Normal 180 Day Track No User Fee |